Long Genocea Biosciences when the price has fallen to last lows
"Genocea Biosciences Inc is a clinical stage biopharmaceutical company that discovers and develops novel vaccines to address infectious diseases for which no vaccine or vaccines with limited effectiveness exist today."
Potential risk:
"Company Insider Jessica Baker Flechtner (Sr. VP of Research) Sells 2,229 Shares of Genocea Biosciences, Inc. (GNCA). The Insider selling transaction was disclosed on Jun 2, 2015 to the Securities and Exchange Commission. "
thedailyrover.com/company-insider-jessica-baker-flechtner-sells-2229-shares-of-genocea-biosciences-inc-gnca/
Potential risk:
"Company Insider Jessica Baker Flechtner (Sr. VP of Research) Sells 2,229 Shares of Genocea Biosciences, Inc. (GNCA). The Insider selling transaction was disclosed on Jun 2, 2015 to the Securities and Exchange Commission. "
thedailyrover.com/company-insider-jessica-baker-flechtner-sells-2229-shares-of-genocea-biosciences-inc-gnca/
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。